ArticleFrontiers in medicine2021

Effect of Spironolactone on COVID-19 in Patients With Underlying Liver Cirrhosis: A Nationwide Case-Control Study in South Korea.

Dongsub Jeon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.